Weichang Zhou
Director/Board Member en WUXI BIOLOGICS (CAYMAN) INC. .
Fortuna: 451 558 $ al 31/03/2024
Perfil
Actualmente, Weichang Zhou ocupa el cargo de Director Ejecutivo, Director de Tecnología y Vicepresidente Ejecutivo en Wuxi Biologics (Cayman), Inc. Anteriormente ocupó el cargo de Director Asociado en Merck & Co. El Dr. Zhou se licenció en la Universidad de Ciencia y Tecnología de Jiangxi y se doctoró en la Universidad de Hannover.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/03/2024 | 247 139 ( 0.01% ) | 451 558 $ | 31/03/2024 |
Cargos activos de Weichang Zhou
| Empresas | Cargo | Inicio |
|---|---|---|
| WUXI BIOLOGICS (CAYMAN) INC. | Director/Board Member | 01/05/2016 |
| WUXI XDC CAYMAN INC. | Director/Board Member | 01/12/2020 |
Antiguos cargos conocidos de Weichang Zhou.
| Empresas | Cargo | Fin |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director/Board Member | 01/12/2012 |
| PDL BIOPHARMA, INC. | Director/Board Member | 01/02/2008 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/10/2002 |
Formación de Weichang Zhou.
| University of Hannover | Doctorate Degree |
| Jiangxi University of Science & Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
| WUXI XDC CAYMAN INC. | Commercial Services |
| Empresas privadas | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Bolsa de valores
- Insiders
- Weichang Zhou
